Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Vein Thrombosis”

183 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 183 results

Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Testing effectiveness (Phase 2)UnknownNCT01834963
What this trial is testing

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Kansai Hepatobiliary Oncology Group 66
Testing effectiveness (Phase 2)Looking for participantsNCT06664996
What this trial is testing

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 33
Not applicableLooking for participantsNCT07461532
What this trial is testing

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

Who this might be right for
CirrhosisSplenectomyPortal Vein Thrombosis+1 more
Northern Jiangsu People's Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07483359
What this trial is testing

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University 38
Not applicableStudy completedNCT03201367
What this trial is testing

Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV

Who this might be right for
Portal Vein Thrombosis
Zagazig University 40
Not applicableUnknownNCT04814251
What this trial is testing

Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study

Who this might be right for
Pancreatic Adenocarcinoma
Poitiers University Hospital 200
Not applicableStudy completedNCT01816256
What this trial is testing

Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms (MPN)Polycythemia Vera (PV)Essential Thrombocythemia (ET)+1 more
University Health Network, Toronto 102
Not applicableStudy completedNCT04966195
What this trial is testing

Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombosisStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT03535259
What this trial is testing

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, Radiotherapy, Sorafenib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 86
Testing effectiveness (Phase 2)Looking for participantsNCT06646198
What this trial is testing

TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension

Who this might be right for
Hepatocellular Carcinoma with PVTT
Fei Gao 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363512
What this trial is testing

Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 27
Not applicableActive Not RecruitingNCT07560202
What this trial is testing

Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and Predictors

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Elham Ahmed Hassan 240
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06632522
What this trial is testing

Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

Who this might be right for
Liver Cancer
Beijing Tsinghua Chang Gung Hospital 46
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Not applicableUnknownNCT03322280
What this trial is testing

TACE Combined With Iodine-125 Seeds Implantation for HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein OcclusionTumor Thrombus
Second Affiliated Hospital of Guangzhou Medical University 270
Testing effectiveness (Phase 2)UnknownNCT04069949
What this trial is testing

Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus

Who this might be right for
Unresectable Hepatocellular CancerPortal Vein Tumor Thrombus
Sichuan University 39
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Not applicableWithdrawnNCT01659346
What this trial is testing

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Thrombosis
Institute of Liver and Biliary Sciences, India
Not applicableUnknownNCT04631458
What this trial is testing

Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis

Who this might be right for
Myeloproliferative NeoplasmSplanchnic Vein ThrombosisSplanchnic Venous Thrombosis+1 more
Royal Free Hospital NHS Foundation Trust 40
Next Page